正海磁材(300224.SZ):部分董事和高管擬減持合計不超269.75萬股
格隆匯6月4日丨正海磁材(300224.SZ)公吿,公司於2021年6月2日收到董事長王慶凱、董事兼總經理李志強、董事兼副總經理趙軍濤、副總經理彭步莊、副總經理王玉林、副總經理兼董事會祕書宋侃、財務總監高波、副總經理史丙強出具的《買賣本公司證券問詢函》,公司董事會根據公司信息披露情況,回覆上述人員《有關買賣本公司證券問詢的確認函》,同意其問詢函中計劃的交易。上述人員計劃減持合計不超269.7473萬股,佔公司總股本的0.3288%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.